Search research articles
Contact Us
Filters
Showing results (551-560 of 573) with videos related to
Page
of 58
Sort By:
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions
|
August 9, 2020
Impact of COVID-19 pandemic on STEMI care: An expanded analysis from the United States
Santiago Garcia, Larissa Stanberry, Christian Schmidt, et al.
Annals of Emergency Medicine
|
December 2, 2004
Standardized reporting guidelines for studies evaluating risk stratification of emergency department patients with potential acute coronary syndromes
Judd E Hollander, Andra L Blomkalns, Gerard X Brogan, et al.
American Heart Journal
|
October 4, 2020
Cardiac safety research consortium "shock II" think tank report: Advancing practical approaches to generating evidence for the treatment of cardiogenic shock
Marc D Samsky, Mitchell W Krucoff, David A Morrow, et al.
Journal of the American College of Cardiology
|
September 13, 2023
Comprehensive Management of ANOCA, Part 2-Program Development, Treatment, and Research Initiatives: JACC State-of-the-Art Review
Nathaniel R Smilowitz, Megha Prasad, R Jay Widmer, et al.
Texas Heart Institute Journal
|
September 17, 2010
LateTIME: a phase-II, randomized, double-blinded, placebo-controlled, pilot trial evaluating the safety and effect of administration of bone marrow mononuclear cells 2 to 3 weeks after acute myocardial infarction
Jay H Traverse, Timothy D Henry, Douglas E Vaughan, et al.
American Heart Journal
|
August 25, 2009
Rationale and design for TIME: A phase II, randomized, double-blind, placebo-controlled pilot trial evaluating the safety and effect of timing of administration of bone marrow mononuclear cells after acute myocardial infarction
Jay H Traverse, Timothy D Henry, Douglas E Vaughan, et al.
Circulation Research
|
August 20, 2014
Detailed analysis of bone marrow from patients with ischemic heart disease and left ventricular dysfunction: BM CD34, CD11b, and clonogenic capacity as biomarkers for clinical outcomes
Christopher R Cogle, Elizabeth Wise, Amy M Meacham, et al.
Journal of the American College of Cardiology
|
September 13, 2023
Comprehensive Management of ANOCA, Part 1-Definition, Patient Population, and Diagnosis: JACC State-of-the-Art Review
Bruce A Samuels, Samit M Shah, R Jay Widmer, et al.
Circulation Research
|
February 21, 2015
Meta-Analysis of Cell-based CaRdiac stUdiEs (ACCRUE) in patients with acute myocardial infarction based on individual patient data
Mariann Gyöngyösi, Wojciech Wojakowski, Patricia Lemarchand, et al.
The New England Journal of Medicine
|
November 18, 2024
Routine Spironolactone in Acute Myocardial Infarction
Sanjit S Jolly, Marc-André d'Entremont, Bertram Pitt, et al.
Page
of 58
Search research articles
Search
Showing results (551-560 of 573) with videos related to
Sort By:
Page
of 58
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions
|
August 9, 2020
Impact of COVID-19 pandemic on STEMI care: An expanded analysis from the United States
Santiago Garcia, Larissa Stanberry, Christian Schmidt, et al.
Annals of Emergency Medicine
|
December 2, 2004
Standardized reporting guidelines for studies evaluating risk stratification of emergency department patients with potential acute coronary syndromes
Judd E Hollander, Andra L Blomkalns, Gerard X Brogan, et al.
American Heart Journal
|
October 4, 2020
Cardiac safety research consortium "shock II" think tank report: Advancing practical approaches to generating evidence for the treatment of cardiogenic shock
Marc D Samsky, Mitchell W Krucoff, David A Morrow, et al.
Journal of the American College of Cardiology
|
September 13, 2023
Comprehensive Management of ANOCA, Part 2-Program Development, Treatment, and Research Initiatives: JACC State-of-the-Art Review
Nathaniel R Smilowitz, Megha Prasad, R Jay Widmer, et al.
Texas Heart Institute Journal
|
September 17, 2010
LateTIME: a phase-II, randomized, double-blinded, placebo-controlled, pilot trial evaluating the safety and effect of administration of bone marrow mononuclear cells 2 to 3 weeks after acute myocardial infarction
Jay H Traverse, Timothy D Henry, Douglas E Vaughan, et al.
American Heart Journal
|
August 25, 2009
Rationale and design for TIME: A phase II, randomized, double-blind, placebo-controlled pilot trial evaluating the safety and effect of timing of administration of bone marrow mononuclear cells after acute myocardial infarction
Jay H Traverse, Timothy D Henry, Douglas E Vaughan, et al.
Circulation Research
|
August 20, 2014
Detailed analysis of bone marrow from patients with ischemic heart disease and left ventricular dysfunction: BM CD34, CD11b, and clonogenic capacity as biomarkers for clinical outcomes
Christopher R Cogle, Elizabeth Wise, Amy M Meacham, et al.
Journal of the American College of Cardiology
|
September 13, 2023
Comprehensive Management of ANOCA, Part 1-Definition, Patient Population, and Diagnosis: JACC State-of-the-Art Review
Bruce A Samuels, Samit M Shah, R Jay Widmer, et al.
Circulation Research
|
February 21, 2015
Meta-Analysis of Cell-based CaRdiac stUdiEs (ACCRUE) in patients with acute myocardial infarction based on individual patient data
Mariann Gyöngyösi, Wojciech Wojakowski, Patricia Lemarchand, et al.
The New England Journal of Medicine
|
November 18, 2024
Routine Spironolactone in Acute Myocardial Infarction
Sanjit S Jolly, Marc-André d'Entremont, Bertram Pitt, et al.
Page
of 58